litlas
Log inCreate account

Hans Lilja

Active 1984–2025

154
Papers
35,090
Citations
96
h-index
153
i10-index

Citations

Citations per year for Hans Lilja1985: 7 citations1986: 1 citations1987: 9 citations1988: 15 citations1989: 20 citations1990: 19 citations1991: 18 citations1992: 31 citations1993: 44 citations1994: 30 citations1995: 83 citations1996: 100 citations1997: 112 citations1998: 105 citations1999: 134 citations2000: 160 citations2001: 119 citations2002: 96 citations2003: 122 citations2004: 129 citations2005: 96 citations2006: 120 citations2007: 149 citations2008: 165 citations2009: 245 citations2010: 352 citations2011: 390 citations2012: 328 citations2013: 350 citations2014: 337 citations2015: 317 citations2016: 291 citations2017: 222 citations2018: 205 citations2019: 599 citations2020: 669 citations2021: 619 citations2022: 436 citations2023: 355 citations2024: 605 citations2025: 216 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,243 citing papers, 24.9% of this breakdownSweden: 726 citing papers, 8% of this breakdownUnited Kingdom: 609 citing papers, 6.7% of this breakdownChina: 584 citing papers, 6.5% of this breakdownGermany: 457 citing papers, 5.1% of this breakdownCanada: 411 citing papers, 4.5% of this breakdownNetherlands: 350 citing papers, 3.9% of this breakdownItaly: 331 citing papers, 3.7% of this breakdownFrance: 277 citing papers, 3.1% of this breakdownDenmark: 276 citing papers, 3.1% of this breakdownAustralia: 227 citing papers, 2.5% of this breakdownFinland: 216 citing papers, 2.4% of this breakdown
0%24.9%Other 25.6%

Institutions

Fields

  • Medicine67%
  • Biochemistry, Genetics and Molecular Biology20.9%
  • Engineering3.3%
  • Immunology and Microbiology2.3%
  • Chemistry1.4%
  • Materials Science1.1%
  • Other4%

Topics

  • Prostate Cancer Treatment and Research12.5%
  • Prostate Cancer Diagnosis and Treatment11.3%
  • Cancer Cells and Metastasis2%
  • Global Cancer Incidence and Screening1.9%
  • Cancer Genomics and Diagnostics1.8%
  • Advanced biosensing and bioanalysis techniques1.6%
  • Other68.9%

Coauthors

All papers

Open in search
  1. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Authors: Jonas Hugosson, Monique J. Roobol, Marianne Månsson, Teuvo L.J. Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, M. Luján, Sigrid Carlsson, Kirsi Talala, Hans Lilja, Louis Denis, Franz Recker, Álvaro Páez, Donella Puliti, Arnauld Villers, Xavier Rébillard, Tuomas P. Kilpeläinen, Ulf‐Håkan Stenman, Rebecka Arnsrud Godtman, Karin Stinesen Kollberg, Sue M. Moss, Paula Kujala, Kimmo Taari, Andreas Huber, Theodorus van der Kwast, Eveline A.M. Heijnsdijk, Chris Bangma, Harry J. de Koning, Fritz H. Schröder, Anssi Auvinen - European Urology 2019 cited by 698

  2. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring

    Authors: Hans Lilja, David Ulmert, Andrew J. Vickers - Nature reviews. Cancer 2008 cited by 919

  3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Authors: Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L.J. Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, M. Luján, Liisa Määttänen, Hans Lilja, Louis Denis, Franz Recker, Álvaro Páez, Chris H. Bangma, Sigrid Carlsson, Donella Puliti, Arnauld Villers, Xavier Rébillard, Matti Hakama, Ulf‐Håkan Stenman, Paula Kujala, Kimmo Taari, Gunnar Aus, Andreas Huber, Theodorus van der Kwast, Ron H. N. van Schaik, Harry J. de Koning, Sue Moss, Anssi Auvinen - The Lancet 2014 cited by 1,565

  4. Intrauterine growth curves based on ultrasonically estimated foetal weights

    Authors: K. Maršál, P‐H. Persson, Torben Larsen, Hans Lilja, Anders Selbing, Beenish I. Sultan - Acta Paediatrica 1996 cited by 1,862

  5. Screening and Prostate-Cancer Mortality in a Randomized European Study

    Authors: Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L.J. Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa, Louis Denis, Franz Recker, Antonio Berenguer, Liisa Määttänen, Chris H. Bangma, Gunnar Aus, Arnauld Villers, Xavier Rebillard, Theodorus van der Kwast, B. G. Blijenberg, Sue M. Moss, Harry J. de Koning, Anssi Auvinen - New England Journal of Medicine 2009 cited by 4,014

  6. Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

    Authors: Maria Frånlund, Marianne Månsson, Rebecka Arnsrud Godtman, Gunnar Aus, Erik Holmberg, Karin Stinesen Kollberg, Pär Lodding, Carl-Gustaf Pihl, Johan Stranne, Hans Lilja, Jonas Hugosson - The Journal of Urology 2022 cited by 90

  7. Prevention and early detection of prostate cancer

    Authors: Jack Cuzick, Mangesh A. Thorat, Gerald L. Andriole, Otis W. Brawley, Powel H. Brown, Zoran Čulig, Rosalind A. Eeles, Leslie G. Ford, Freddie C. Hamdy, Lars Holmberg, Dragan Ilić, Timothy J. Key, Carlo La Vecchia, Hans Lilja, Michael Marberger, Frank L. Meyskens, Lori M. Minasian, Chris Parker, Howard L. Parnes, Sven Perner, Harry G. Rittenhouse, Jack A. Schalken, Hans Peter Schmid, Bernd J. Schmitz‐Dräger, Fritz H. Schröder, Arnulf Stenzl, Bertrand Tombal, Timothy J Wilt, Alicja Wolk - The Lancet Oncology 2014 cited by 492

  8. Prostate-Cancer Mortality at 11 Years of Follow-up

    Authors: Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L.J. Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, M. Luján, Hans Lilja, Marco Zappa, Louis Denis, Franz Recker, Álvaro Páez, Liisa Määttänen, Chris H. Bangma, Gunnar Aus, Sigrid Carlsson, Arnauld Villers, Xavier Rébillard, Theodorus van der Kwast, Paula Kujala, B. G. Blijenberg, Ulf‐Håkan Stenman, Andreas Huber, Kimmo Taari, M Hakama, Sue Moss, Harry J. de Koning, Anssi Auvinen - New England Journal of Medicine 2012 cited by 1,241

  9. Acoustic Enrichment of Extracellular Vesicles from Biological Fluids

    Authors: Anson T. Ku, Hooi Ching Lim, Mikael Evander, Hans Lilja, Thomas Laurell, Stefan Scheding, Yvonne Ceder - Analytical Chemistry 2018 cited by 132

  10. Genetically adjusted PSA levels for prostate cancer screening

    Authors: Linda Kachuri, Thomas J. Hoffmann, Yu Jiang, Sonja I. Berndt, John P. Shelley, Kerry Schaffer, Mitchell J. Machiela, Neal D. Freedman, Wen‐Yi Huang, Shengchao A. Li, Ryder Easterlin, Phyllis J. Goodman, Cathee Till, Ian M. Thompson, Hans Lilja, Stephen K. Van Den Eeden, Stephen J. Chanock, Christopher A. Haiman, David V. Conti, Robert J. Klein, Jonathan D. Mosley, Rebecca E. Graff, John S. Witte - Nature Medicine 2023 cited by 75

  11. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

    Authors: Jonas Hugosson, Sigrid Carlsson, Gunnar Aus, Svante Bergdahl, Ali Khatami, Pär Lodding, Carl‐Gustaf Pihl, Johan Stranne, Erik Holmberg, Hans Lilja - The Lancet Oncology 2010 cited by 936

  12. Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI

    Authors: Anssi Auvinen, Teuvo L.J. Tammela, Tuomas Mirtti, Hans Lilja, Teemu Tolonen, Anu Kenttämies, Irina Rinta‐Kiikka, Terho Lehtimäki, Kari Natunen, Jaakko Nevalainen, Jani Raitanen, Johanna Ronkainen, Theodorus van der Kwast, Jarno Riikonen, Anssi Pétas, Mika Matikainen, Kimmo Taari, Tuomas P. Kilpeläinen, Antti Rannikko, ProScreen Trial Investigators, Paula Kujala, Teemu J. Murtola, Juha Koskimäki, Antti Kaipia, Tomi Pakarainen, Suvi Marjasuo, Juha Oksala, Tuomas Saarinen, Kirsty Ijäs, Into Kiviluoto, Juhani Kosunen, Arja Pauna, Arya Yar, Pekka Ruusuvuori, Neill Booth, Jill Hannus, Sanna Huovinen, Marita Laurila, Johanna Pulkkinen, Mika Tirkkonen, Mona Hassan Al-Battat - JAMA 2024 cited by 88

  13. Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

    Authors: Richard J. Bryant, Daniel D. Sjoberg, Andrew J. Vickers, Mary Robinson, Rajeev Kumar, Luke Marsden, Michael Davis, Peter T. Scardino, Jenny Donovan, David E. Neal, Hans Lilja, Freddie C. Hamdy - JNCI Journal of the National Cancer Institute 2015 cited by 182

  14. Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial

    Authors: Rebecka Arnsrud Godtman, Erik Holmberg, Hans Lilja, Johan Stranne, Jonas Hugosson - European Urology 2014 cited by 166

  15. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Authors: Daniel C. Danila, Glenn Heller, Gretchen A. Gignac, Rita Gonzalez-Espinoza, Aseem Anand, Erika Tanaka, Hans Lilja, Lawrence B. Schwartz, Steven M. Larson, Martin Fleisher, Howard I. Scher - Clinical Cancer Research 2007 cited by 673

  16. Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

    Authors: Andrew J. Stephenson, Michael W. Kattan, James A. Eastham, Zohar Dotan, Fernando J. Bianco, Hans Lilja, Peter T. Scardino - Journal of Clinical Oncology 2006 cited by 526

  17. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

    Authors: Catharine M. Sturgeon, Michael J. Duffy, Ulf‐Håkan Stenman, Hans Lilja, Nils Brünner, Daniel W. Chan, Richard J. Babaian, Robert C. Bast, Barry L. Dowell, Francisco J. Esteva, Caj Haglund, Nadia Harbeck, Daniel F. Hayes, Mads Holten-Andersen, George G. Klee, R. Lamerz, Leendert H. J. Looijenga, Rafael Molina, Hans Jørgen Nielsen, Harry G. Rittenhouse, Axel Semjonow, Ie‐Ming Shih, Paul Sibley, György Sölétormos, Carsten Stephan, Lori J. Sokoll, Barry Hoffman, Eleftherios P. Diamandis - Clinical Chemistry 2008 cited by 1,134

  18. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

    Authors: Tobias Nordström, Andrew J. Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund - European Urology 2014 cited by 214

  19. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

    Authors: Andrew J. Vickers, David Ulmert, Daniel D. Sjoberg, Caroline Bennette, Thomas Björk, Axel Gerdtsson, Jonas Manjer, Peter M. Nilsson, Anna M. Dahlin, Anders Bjartell, Peter T. Scardino, Hans Lilja - BMJ 2013 cited by 281

  20. Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial

    Authors: Sigrid Carlsson, Rebecka Arnsrud Godtman, Carl‐Gustav Pihl, Andrew J. Vickers, Hans Lilja, Jonas Hugosson, Marianne Månsson - European Urology 2022 cited by 36

  21. Microfluidic, Label-Free Enrichment of Prostate Cancer Cells in Blood Based on Acoustophoresis

    Authors: Per Augustsson, Cecilia Magnusson, Maria Nordin, Hans Lilja, Thomas Laurell - Analytical Chemistry 2012 cited by 347

  22. Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality

    Authors: Jonas Hugosson, Rebecka Arnsrud Godtman, Sigrid Carlsson, Gunnar Aus, Anna Grenabo Bergdahl, Pär Lodding, Carl‐Gustaf Pihl, Johan Stranne, Erik Holmberg, Hans Lilja - Scandinavian Journal of Urology 2017 cited by 107

  23. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

    Authors: Elizabeth Bancroft, Elizabeth Page, Mark N. Brook, Sarah Thomas, Natalie Taylor, Jennifer Pope, Jana McHugh, Ann-Britt Jones, Questa Karlsson, Susan Merson, Kai Ren Ong, Jonathan Hoffman, Camilla Huber, Lovise Mæhle, Eli Marie Grindedal, Astrid Stormorken, D. Gareth Evans, Jeanette Rothwell, Fiona Lalloo, Angela F. Brady, Marion Bartlett, Katie Snape, Helen Hanson, Paul A. James, Joanne McKinley, Lyon Mascarenhas, Sapna Syngal, Chinedu Ukaegbu, Lucy Side, Tessy Thomas, Julian Barwell, Manuel R. Teixeira, Louise Izatt, Mohnish Suri, Finlay Macrae, Nicola Poplawski, Rakefet Chen‐Shtoyerman, Munaza Ahmed, Hannah Musgrave, Nicola Nicolai, Lynn Greenhalgh, Carole Brewer, Nicholas Pachter, Allan D. Spigelman, Ashraf Azzabi, Brian T. Helfand, Dorothy Halliday, Saundra S. Buys, Teresa Ramón y Cajal, Alan Donaldson, Kathleen A. Cooney, Marion Harris, John McGrath, Rosemarie Davidson, Amy Taylor, Peter Cooke, Kathryn Myhill, Matthew Hogben, Neil K. Aaronson, Audrey Ardern‐Jones, Chris H. Bangma, Elena Castro, David P. Dearnaley, Alexander Dias, Tim Dudderidge, Diana M Eccles, Kate Green, Jórunn E. Eyfjörd, Alison Falconer, Christopher S. Foster, Henrik Grönberg, Freddie C. Hamdy, Oskar T. Johannsson, Vincent Khoo, Hans Lilja, Geoffrey J. Lindeman, Jan Lubiński, Karol Axcrona, Christos Mikropoulos, Anita Mitra, Clare Moynihan, Holly Ní Raghallaigh, Gad Rennert, Rebecca Collier, Lisa K. Adams, Julian Adlard, Rosa Alfonso, Saira Ali, Angela Andrew, Luís Araújo, Nazya Azam, Darran Ball, Queenstone Barker, Alon Basevitch, Barbara Benton, Cheryl Berlin, Nicola Bermingham, Leah H. Biller, Angela Bloss, Matilda Bradford and 218 more - The Lancet Oncology 2021 cited by 93

  24. Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years

    Authors: Evan Kovac, Sigrid Carlsson, Hans Lilja, Jonas Hugosson, Michael W. Kattan, Erik Holmberg, Andrew J. Stephenson - JAMA Network Open 2020 cited by 52